Lazard Asset Management’s Bausch Health BHC Stock Holding History

Lazard Asset Management’s Portfolio BHC Stock Details BHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$287K	Buy	53,139 +7,114	+15%	+$42.6K	﹤0.01%	1514
2025 Q4	$320K	Buy	46,025 +6,194	+16%	+$40.7K	﹤0.01%	1507
2025 Q3	$256K	Buy	+39,831	New	+$272K	﹤0.01%	1530
2024 Q3	–	Sell	-5,240	Closed	-$36K	–	2269
2024 Q2	$36K	Hold	5,240	–	–	﹤0.01%	1974
2024 Q1	$55K	Sell	5,240 -395	-7%	-$3.45K	﹤0.01%	1700
2023 Q4	$45K	Sell	5,635 -574	-9%	-$4.18K	﹤0.01%	1911
2023 Q3	$51K	Hold	6,209	–	–	﹤0.01%	1847
2023 Q2	$49K	Buy	+6,209	New	+$45.8K	﹤0.01%	1840
2020 Q1	–	Sell	-1,691	Closed	-$50K	–	1582
2019 Q4	$50K	Buy	+1,691	New	+$44K	﹤0.01%	1057
2016 Q4	–	Sell	-1	Closed	–	–	992
2016 Q3	$0	Hold	1	–	–	﹤0.01%	988
2016 Q2	$0	Hold	1	–	–	﹤0.01%	1044
2016 Q1	$0	Hold	1	–	–	﹤0.01%	1040
2015 Q4	$0	Hold	1	–	–	﹤0.01%	1102
2015 Q3	$0	Sell	1 -1,519	-100%	-$354K	﹤0.01%	1087
2015 Q2	$337K	Buy	+1,520	New	+$337K	﹤0.01%	786

Other funds holding BHC

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

GAM

Goldentree Asset Management New York $1.69B AUM 10.69% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

MFN Partners Boston, Massachusetts $4.77B AUM 72.29% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

KKRC

Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Lazard Asset Management's BHC Position: Q1 2026 in Review

Lazard Asset Management increased its Bausch Health (BHC) stake by 15% in Q1 2026, buying an estimated $42.6K and bringing the position to 53,139 shares worth $287K. The position accounts for ﹤0.01% of the portfolio, ranked #1514.

Lazard Asset Management first reported a position in BHC in Q2 2015 and has held it in 15 quarters since. The position peaked at $337K in Q2 2015. 227 funds tracked by Wall St. Rank hold BHC as of Q1 2026.

Lazard Asset Management held 53,139 shares of Bausch Health worth $287K as of Q1 2026.
Lazard Asset Management bought 7,114 Bausch Health shares in Q1 2026, an estimated $42.6K.
Bausch Health made up ﹤0.01% of Lazard Asset Management's portfolio in Q1 2026, its #1514 holding.
Lazard Asset Management first reported a position in Bausch Health in Q2 2015 and has held it in 15 quarters since.
Lazard Asset Management's Bausch Health position peaked at $337K in Q2 2015.
227 funds tracked by Wall St. Rank held Bausch Health as of Q1 2026.

Based on Lazard Asset Management's 13F filing for Q1 2026, filed 15 May 2026.